PAYMENT RATE CUTS FOR CLINICAL LABORATORY TESTS, called for under the Protecting Access to Medicare Act of 2014 (PAMA), have been avoided temporarily—again. A down-to-the-wire bill in Congress to keep the federal government funded into the new year included a provision to delay PAMA cuts to the Clinical Laboratory Fee Schedule (CLFS) for 2023. This …
PAMA Cuts Have Simply Been Kicked Down the Road
PAMA Cuts Have Simply Been Kicked Down the Road Read More »
Comments
Volume XXX, No. 1 – January 3, 2023
TABLE OF CONTENTS
COMMENTARY & OPINION BY R. LEWIS DARK
ARTICLES
INTELLIGENCE
Need A Group Membership? Company Discounts are Available!